NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Frank Vari
QIMR Berghofer Medical Research Institute - Herston / Australia
Medical and Health Sciences / Immunology
AD Scientific Index ID: 4461757
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Frank Vari's MOST POPULAR ARTICLES
1-)
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCLF Vari, D Arpon, C Keane, MS Hertzberg, D Talaulikar, S Jain, Q Cui, ...Blood, The Journal of the American Society of Hematology 131 (16), 1809-1819, 20182352018
2-)
Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphomaK Jones, F Vari, C Keane, P Crooks, JP Nourse, LA Seymour, D Gottlieb, ...Clinical cancer research 19 (3), 731-742, 20131122013
3-)
Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltrationJWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ...Journal of Clinical Oncology 37 (34), 3300, 2019912019
4-)
CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cellsM Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ...Immunity 53 (4), 805-823. e15, 20201092020
5-)
A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A* 0201 peptides for immunotherapy of metastatic hormone refractory prostate cancerRL Prue, F Vari, KJ Radford, H Tong, MY Hardy, R D’Rozario, ...Journal of immunotherapy 38 (2), 71-76, 20151012015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept